[Express Train - Episode 87] Ubicare Expected to Lead the Non-Face-to-Face Medical Market

Ubicare has developed an integrated management solution that maximizes the efficiency of related tasks from reception, consultation, prescription dispensing, insurance claims, to management in medical environments such as hospitals, clinics, and pharmacies. It has established the largest medical network in Korea and provides medical information platform and personal health information management platform services. It holds a 45% market share in the domestic electronic medical record (EMR) market for nursing institutions. EMR is a system that inputs, organizes, and stores patient reception and consultation details, tests, and surgical records electronically. The sales composition by business is 47% from EMR solutions, 42% from distribution solutions, 8.3% from pharmaceutical and data analysis solutions, and 3.2% from health management solutions.

Since 2016, Ubicare has expanded its corporate scale through mergers and acquisitions (M&A) of similar companies. It acquired Vibros, which operates the hospital and clinic reservation mobile service 'Ddokdak', in 2016, and Brain Healthcare, an EMR company for nursing and oriental medicine hospitals, in 2018.

The solutions provided by Ubicare include 'Uisalang Pre-Check', 'Uisalang e-Sign', and 'Uisalang Lab'. Uisalang Pre-Check helps ensure appropriate medical treatment by providing real-time notifications on the Health Insurance Review and Assessment Service (HIRA) nursing care benefit cost standards, various latest notices, and review guidelines on the consultation room claim screen.

Patent attorney Um Jeonghan from BLT Patent Law Firm reviewed Ubicare's patent and trademark application status.

Listed companies on the domestic stock market disclose patent acquisition information through the Financial Supervisory Service's electronic disclosure system. However, many stock investors tend to overlook patent disclosures.

Not only patents but also trademark registrations indicate the future direction of listed companies, making them one of the important indicators for assessing future corporate value. Some patent disclosures even act as direct triggers for stock price increases.

It is not easy for general investors to understand the impact on companies through patent disclosures or to check trademark application statuses one by one. Asia Economy is reviewing the patent and trademark application status of listed companies together with patent attorney Um Jeonghan from BLT Patent Law Firm through 'Special Express Train'.

'Special Express Train' is an abbreviation for a broadcast that diligently searches for rapidly rising stocks through patents.

This content was produced with the assistance of AI translation services.